On Friday, May 12th, Michael Nestor sold 700 shares of Impax Laboratories stock. The shares were sold at an average price of $17.11, for a total transaction of $11,977.00. Impax Laboratories Inc (NASDAQ:IPXL) traded down 1.83% on …
BNS7d
Sells
RBC Capital Markets maintained Impax Laboratories Inc (NASDAQ:IPXL) on Thursday, November 10 with “Sector …
Energen
At the movement Impax Laboratories, Inc. (NASDAQ:IPXL) is under coverage by number of analysts. Buy rating has …
NASDAQ
Impax Laboratories Inc. (IPXL) traded on unusually high volume on May. 11, as the stock gained 3.02% to close at $17.05. On the day, Impax Laboratories Inc. saw 4.33 million shares trade hands on 21,180 trades. Considering that the stock
Impax Laboratories
The original version of this piece of content can be read at https://transcriptdaily.com/2017/05/18/impax-laboratories-inc-ipxl-stock-rating-upgraded-by-zacks-investment-research-updated.html. The oscillator ranges from 0 to -100. For the …
Impax Laboratories Inc (NASDAQ:IPXL)‘s stock had its “outperform” rating reiterated by equities research analysts at Royal Bank of Canada in a research note issued to investors on Thursday. They presently have a $62.00 price target on …
The shares were sold at an average price of $17.11, for a total transaction of $11,977.00. (NASDAQ:IPXL) stock went gone down with a prior 52-week high of $35.24.During the session shares traded on below-average volume. Ameriprise …